CTNM
#3119
Contineum Therapeutics, Inc. - Common stock
16.0 7 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.05%
Variación mensual
+5.58%
Variación en los últimos 6 meses
+6.14%
Cambio anual
+5.24%
Cierres anteriores
16.2 4
Open
16.0 7
Mínimo
15.8 1
Máximo
16.1 9
Volumen
14
Financials
- Market Capitalization 371.2 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3095 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.36 USD | +0.23% | -10.22% | +5.20% | +53.56% | 389.12 M USD | ||
| 3096 |  EYPT EyePoint, Inc. - Common Stock | 4.40 USD | -2.22% | -15.38% | -64.34% | -63.33% | 379.33 M USD | ||
| 3126 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.01 USD | -1.95% | -8.64% | -1.95% | +310.20% | 363.96 M USD | ||
| 3170 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.28 USD | -0.28% | -6.91% | +9.43% | -40.97% | 349.93 M USD |